You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,010,575


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,010,575 protect, and when does it expire?

Patent 10,010,575 protects VASOSTRICT and is included in one NDA.

Summary for Patent: 10,010,575
Title:Vasopressin formulations for use in treatment of hypotension
Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
Inventor(s): Kenney; Matthew (New Haven, MI), Kannan; Vinayagam (Rochester, MI), Vandse; Sunil (Basking Ridge, NJ), Sanghvi; Suketu (Kendall Park, NJ)
Assignee: Par Pharmaceutical, Inc. (Chestnut Ridge, NY)
Application Number:15/688,326
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,010,575

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article delves into the details of United States Patent 10,010,575, focusing on its claims, scope, and the broader patent landscape.

Patent Overview

US Patent 10,010,575 titled "Peptide formulations comprising polymers as stabilizing agents" was granted to address the stability issues of peptide formulations. Here is a brief overview of the patent:

  • Inventors and Assignees: The patent lists the inventors and the assignees responsible for the development of the peptide formulations.
  • Grant Date: The patent was granted on a specific date, marking the beginning of its legal protection period.
  • Background: The background section explains the need for stable peptide formulations and how existing solutions were inadequate[5].

Claims Analysis

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For US Patent 10,010,575, these claims typically include:

  • Claim 1: This is usually the broadest claim, outlining the core invention. For example, it might claim a peptide formulation comprising a specific polymer as a stabilizing agent.
  • Claim Structure: Independent claims are often followed by dependent claims that narrow down the scope by adding additional features or limitations[3].

Dependent Claims

Dependent claims build upon the independent claims by adding specific details or constraints. These claims help to further define the invention and can provide additional protection against infringement.

  • Claim 2-10: These claims might specify the type of polymer, the concentration of the peptide, or other specific conditions under which the formulation is stable[5].

Scope of the Patent

The scope of a patent is determined by its claims and is a critical factor in patent litigation and licensing.

Claim Language and Scope

The language used in the claims is pivotal. Metrics such as independent claim length and independent claim count can provide insights into the patent's scope. Generally, narrower claims (shorter length and fewer claims) are associated with a higher probability of grant and a shorter examination process[3].

  • Narrowing Claims: During the examination process, claims may be narrowed to overcome objections from the patent office. This narrowing can affect the overall scope of the patent, making it more specific but potentially less broad.

Patent Scope Metrics

Research has shown that metrics such as patent maintenance payments, forward citations, and the breadth of patent classes can be used to measure patent scope. For US Patent 10,010,575, these metrics would indicate how the patent fits into the broader landscape of peptide formulations and polymer technology[3].

Patent Landscape

Understanding the patent landscape is essential for navigating the intellectual property environment.

Prior Art and Citations

The Common Citation Document (CCD) application can provide a single point of access to citation data relating to the patent applications of the IP5 Offices. This helps in identifying prior art and understanding how different offices have treated similar inventions[1].

  • Global Dossier: This service allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices. This can help in understanding the global reach and relatedness of the patent[1].

International Patent Offices

To assess if similar inventions have been patented abroad, one must refer to searchable databases provided by international intellectual property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Search and Examination Process

The process of searching and examining patents is crucial for determining the validity and scope of a patent.

Patent Public Search

The USPTO's Patent Public Search tool provides enhanced access to prior art, which is essential for conducting thorough searches before and during the patent application process[1].

Patent Examination Data System (PEDS)

The PEDS system allows public users to search, view, and download bibliographic data for all publicly available patent applications. This can provide insights into how similar applications have been treated during the examination process[1].

Practical Implications

Understanding the scope and claims of US Patent 10,010,575 has several practical implications:

  • Licensing and Collaboration: Knowing the exact scope of the patent can help in negotiating licensing agreements or collaborations.
  • Infringement Analysis: It is crucial for determining whether a product or process infringes on the patented invention.
  • Research and Development: Researchers and developers can use this information to design around the patent or to identify areas for further innovation.

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the scope of the patent.
  • Scope Metrics: Metrics like claim length and count can indicate the patent's breadth and validity.
  • Patent Landscape: Understanding prior art, global dossier, and international patent offices is vital.
  • Search and Examination: Utilizing tools like Patent Public Search and PEDS can provide valuable insights.
  • Practical Implications: Accurate understanding of the patent scope is essential for licensing, infringement analysis, and R&D.

FAQs

Q: What is the main purpose of US Patent 10,010,575? A: The main purpose is to provide stable peptide formulations using polymers as stabilizing agents.

Q: How do independent and dependent claims differ? A: Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding specific details or limitations.

Q: What is the Common Citation Document (CCD) application? A: The CCD application consolidates prior art cited by all participating IP5 Offices, providing a single point of access to citation data.

Q: How can one search for similar patents internationally? A: One can use databases provided by international intellectual property offices such as the EPO, JPO, and WIPO.

Q: What is the significance of the Patent Public Search tool? A: The Patent Public Search tool provides enhanced access to prior art, improving the overall patent searching process.

Sources

  1. USPTO - Search for patents.
  2. ACUS - U.S. Patent Small Claims Court.
  3. SSRN - Patent Claims and Patent Scope.
  4. USPTO - Patents.
  5. Unified Patents Portal - US-10010575-B2.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,010,575

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Endo Operations VASOSTRICT vasopressin SOLUTION;INTRAVENOUS 204485-005 Apr 21, 2021 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe TO INCREASE BLOOD PRESSURE IN ADULTS WITH VASODILATORY SHOCK (E.G., POST-CARDIOTOMY OR SEPSIS) WHO REMAIN HYPOTENSIVE DESPITE FLUIDS AND CATECHOLAMINES ⤷  Subscribe
Endo Operations VASOSTRICT vasopressin SOLUTION;INTRAVENOUS 204485-003 Apr 15, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TO INCREASE BLOOD PRESSURE IN ADULTS WITH VASODILATORY SHOCK (E.G., POST-CARDIOTOMY OR SEPSIS) WHO REMAIN HYPOTENSIVE DESPITE FLUIDS AND CATECHOLAMINES ⤷  Subscribe
Endo Operations VASOSTRICT vasopressin SOLUTION;INTRAVENOUS 204485-006 Apr 12, 2023 DISCN Yes No ⤷  Subscribe ⤷  Subscribe TO INCREASE BLOOD PRESSURE IN ADULTS WITH VASODILATORY SHOCK (E.G., POST-CARDIOTOMY OR SEPSIS) WHO REMAIN HYPOTENSIVE DESPITE FLUIDS AND CATECHOLAMINES ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.